Enteric coating compositions, enteric coating films, and formulations containing them
By using a combination of HPMPCP, plasticizer, and pH adjuster in a non-aqueous coating method, the problems of long coating time and stability in non-aqueous coating are solved, achieving efficient and stable enteric coating suitable for various capsule types.
Patent Information
- Application Number
- CN202580026366.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-04
- Filing Date
- 2025-02-19
- Publication Date
- 2026-11-17
AI Technical Summary
Existing non-aqueous coating methods are time-consuming and costly when preparing enteric-coated formulations. Furthermore, it is difficult to maintain uniform quality when the process environment changes, especially at low temperatures where capsule surface turbidity or poor formulation hardening may occur.
An enteric coating composition containing hydroxypropyl methylcellulose phthalate (HPMCP), triacetin, or acetylated monoglycerides as plasticizers and sodium bicarbonate (baking soda) as a pH adjuster is used to adjust the pH to the range of 2.5 to 7.0 for non-aqueous coating methods to improve coating efficiency.
It shortens the coating time, reduces the amount of coating, avoids turbidity on the capsule surface and poor hardening of the formulation, and improves coating efficiency and stability. It is suitable for hard capsules, soft capsules and empty hard capsules.
Smart Images

Figure CN123124968A_ABST
Abstract
Description
Technical Field
[0001] This disclosure relates to an enteric coating composition, an enteric coating film, and a formulation comprising the same. Background Technology
[0002] Enteric-coated formulations are dosage forms designed to delay drug dissolution for a certain period of time after administration. They are usually prepared by special formulations or methods, so that they do not disintegrate or dissolve in gastric juice conditions (pH about 1.2) for a certain period of time, but disintegrate and dissolve in intestinal juice conditions (pH about 6.8) for a certain period of time.
[0003] To prepare enteric-coated formulations, film coating is commonly used. Film coating methods can be categorized into aqueous coating and non-aqueous coating based on the solvent used. Aqueous coating uses water as the solvent, while non-aqueous coating uses a mixture of solvents containing organic solvents. Aqueous coating is economical and environmentally friendly due to its lower solvent usage, and unlike non-aqueous coating (also known as oil-based coating), it does not pose an explosion risk. Examples of enteric-coated soft capsule compositions using aqueous coating are disclosed in Korean Patent Registration No. 10-1380652, Korean Patent Publication No. 10-2015-0079282, and Korean Patent Publication No. 10-2020-0117883, among others. However, aqueous coating requires evaporation of water at relatively high temperatures, which can significantly affect the dosage form and also results in a longer coating time compared to non-aqueous coating. In particular, the long coating time is a major drawback and a limiting factor for improving productivity. This is precisely why most companies preparing enteric-coated formulations still use non-aqueous coatings, despite facing stability issues with them.
[0004] However, there is still room for improvement in the methods for preparing enteric-coated formulations using non-aqueous coating. Enteric-coated formulations require a larger coating layer than other coated formulations to ensure stable enteric properties. Therefore, the coating film is relatively thicker, requiring a longer coating time and a larger coating amount, which increases product cost. Furthermore, depending on the characteristics of the contents, maintaining uniform quality can be difficult when the process environment changes.
[0005] Existing technical documents: Korean Patent Registration No. 10-1380652 (registered on March 27, 2014); Korean Patent Publication No. 10-2015-0079282 (published on July 8, 2015); Korean Patent No. 10-2020-0117883 (published on October 14, 2020). Summary of the Invention
[0006] The purpose of this disclosure is to provide an enteric coating composition, an enteric coating film, and a formulation comprising the enteric coating composition that can improve coating efficiency in a non-aqueous coating manner.
[0007] According to one aspect of this disclosure, an enteric coating composition is provided comprising: hydroxypropyl methylcellulose phthalate (HPMCP); a plasticizer selected from triacetin or acetylated monoglyceride; a mixed solvent containing purified water and ethanol; and a pH adjuster for adjusting the pH to a range of 2.5 to 7.0, said pH adjuster being sodium bicarbonate (baking soda, NaHCO3).
[0008] At this point, the composition may be 50 to 150 parts by weight of hydroxypropyl methylcellulose phthalate (HPMCP), 125 to 210 parts by weight of purified water, 725 to 980 parts by weight of ethanol, 10 to 65 parts by weight of plasticizer, and 1 to 6 parts by weight of pH adjuster.
[0009] In addition, the hydroxypropyl methylcellulose phthalate (HPMCP) may be selected from HPMCP-HP 50, HPMCP-HP 55 or HPMCP-HP 55S.
[0010] According to another aspect of this disclosure, an enteric coating film formed from the above-described enteric coating composition may be further provided.
[0011] According to another aspect of this disclosure, formulations comprising the enteric coating film may be further provided.
[0012] At this time, the dosage form of the preparation can be selected from tablets, hard capsules, empty hard capsules and soft capsules.
[0013] Invention Effects When preparing enteric-coated films using the enteric-coating composition according to embodiments of the present disclosure, the coating speed can be increased compared to existing non-aqueous coating methods. Therefore, the coating time can be shortened and the coating amount reduced, thereby improving coating efficiency. Furthermore, no capsule surface turbidity or poor formulation hardening occurs after the coating process. Attached Figure Description
[0014] Figure 1 Photo a is a photograph of Comparative Example 1, in which a white clouding phenomenon occurred on the surface of the capsule, and a photograph of Example 3, in which no white clouding phenomenon occurred; Figure 1 Photograph b shows the hardening of the excipients in comparative examples 1 and 2.
[0015] Figure 2Photographs of Comparative Example 1 showing the occurrence of turbidity on the surface (junction) of Omega-3 soft capsules, and Example 3 showing no turbidity.
[0016] Figure 3 A photograph showing the separated state of the coated hollow hard capsule in Example 5 after coating. Detailed Implementation
[0017] The present disclosure will now be described in detail with reference to the accompanying drawings. The following description should be understood as an illustration of the present disclosure through specific examples, and the technical concept of the present disclosure is not limited to the following description. Furthermore, the accompanying drawings are provided to aid in understanding the present disclosure, and the technical concept of the present disclosure is not limited to the accompanying drawings.
[0018] Terminology Definition The terms used in this disclosure may be defined as follows.
[0019] "Enteric properties" can refer to the property of not disintegrating for more than 2 hours under in vitro gastric conditions (pH 1.2), but disintegrating within 1 hour under in vitro intestinal conditions (pH 6.8).
[0020] A "hard capsule" can refer to a formulation comprising a shell material consisting of a pair of interlocking capsule substrates and a fill material filling the shell. It can also include a pair of capsule substrates consisting only of the shell material, without any fill material. In the latter case, it can also be referred to as an "empty capsule" or "hollow hard capsule," etc.
[0021] "Soft capsule" can refer to a liquid preparation that consists of a single smooth shell material and a filling material inside the shell.
[0022] "Tablet" can refer to a preparation made by compressing granules or powder into a certain shape.
[0023] Enteric coating composition This disclosure provides an enteric coating composition. An enteric coating composition according to one embodiment of this disclosure may comprise: an enteric compound; a plasticizer; a mixed solvent containing an organic solvent; and a pH adjuster to adjust the pH upwards. The enteric coating composition can be used in solution form and is hereinafter referred to as an "enteric coating solution".
[0024] An enteric coating composition according to an embodiment of the present disclosure may comprise 50 to 150 parts by weight of an enteric compound, 125 to 210 parts by weight of purified water, 725 to 980 parts by weight of an organic solvent, 10 to 65 parts by weight of a plasticizer, and 1 to 6 parts by weight of a pH adjuster.
[0025] Enteric-coated compounds may include hydroxypropyl methylcellulose phthalate (HPMCP), hydroxypropyl methylcellulose acetate succinate (HPMCAS), cellulose acetate phthalate (CAP), polyvinyl acetate phthalate (PVAP), and copolymers of methacrylic acid and ethyl acrylate (Eudragit), as well as their respective derivatives or mixtures thereof.
[0026] In one example, the enteric compound may be hydroxypropyl methylcellulose phthalate (hereinafter, HPMCP). HPMCP is a cellulose derivative that is a major component of plant cell walls. Commercially available products can be used for HPMCP, which are classified according to their viscosity, such as HPMCP-HP 50, HPMCP-HP 55, HPMCP-HP55S, etc. There are no particular limitations on the HPMCP that can be used in the enteric coating composition according to the embodiments of this disclosure, and multiple different HPMCP products can be mixed.
[0027] When plasticizers are used in the formation of enteric coating films using enteric coating compositions, they can contribute to a uniform surface of the coating film and prevent cracking of the enteric coating film. In one example, the plasticizer may be selected from triacetin, acetylated monoglyceride, triethylcitrate, glycerin esters of fatty acids, or mixtures thereof, but is not limited thereto.
[0028] In one example, the plasticizer can be a commercially available product, such as Almax-5000 (product name), a commercially available product of acetylated monoglycerides.
[0029] The mixed solvent may be an organic solvent or a mixed solvent containing an organic solvent. Here, the organic solvent may be one or more selected from the group consisting of acetone, ethanol, dichloromethane, dioxane, methanol and isopropanol, but is not limited thereto.
[0030] In one example, the mixed solvent could be a mixture of acetone and ethanol. In another example, the mixed solvent could refer to a mixture of an organic solvent and water (specifically, purified water), such as a mixture of water (purified water) and ethanol.
[0031] The pH adjuster can adjust the pH of the enteric coating composition upwards. More specifically, the pH adjuster can adjust the pH of the enteric coating composition upwards to about 2.5 to 7.0, more specifically to about 2.5 to 6.8, and even more specifically to about 2.8 to 6.8. The pH adjuster can be one or more selected from the group consisting of sodium hydroxide (NaOH), potassium hydroxide (KOH), ammonia, triethylamine (TEA), trimethylamine (TMA), ammonium bicarbonate ((NH4)HCO3), sodium bicarbonate (baking soda, NaHCO3), sodium phosphate, tribasic sodium phosphate, disodium pyrophosphate, and sodium pyrophosphate. In one example, the pH adjuster can be sodium bicarbonate (baking soda).
[0032] A feature of this disclosure is that, when forming an enteric coating film using a non-aqueous coating method, a pH adjuster is used to adjust the pH of the enteric coating solution upwards. As mentioned above, non-aqueous coating methods have relatively higher productivity than aqueous coating methods and are commonly used by companies preparing enteric formulations. However, unlike aqueous coating methods, existing non-aqueous coating methods have never used pH adjusters. This is because enteric compounds are not easily soluble in water but are relatively soluble in organic solvents. Therefore, in aqueous coating methods, pH adjusters are used to help enteric compounds dissolve in water, but it is understood that existing oil-based coating methods do not recognize the necessity of pH adjusters. However, the inventors of this disclosure have discovered that in oil-based coating methods, if a pH adjuster is used to adjust the pH of the enteric coating solution upwards, just as in aqueous coating methods, the coating efficiency will also be improved, thus completing this disclosure.
[0033] Existing non-aqueous coating methods are highly sensitive to process environments (such as moisture and temperature), often resulting in turbidity (cloudy appearance) or poor formulation hardening after coating. For example, the pH of non-aqueous enteric coating solutions is approximately 2; the presence of moisture at this pH often leads to incomplete film formation. However, increasing the drying temperature (e.g., above 35°C) to remove moisture can adversely affect the capsule contents (e.g., causing lactic acid bacteria to die if the contents are lactic acid bacteria); conversely, decreasing the drying temperature (e.g., below 25°C) to reduce the impact on the capsule contents leads to excessively long coating times, increased product costs, and formulation hardening. Furthermore, to stably meet enteric properties (remaining intact for more than 2 hours at pH 1.2 in vitro), a thicker coating layer is required, resulting in increased product costs due to longer coating times and excessive use of raw materials. Against this backdrop, embodiments of this disclosure propose using a pH adjuster in non-aqueous coating methods. As shown in the embodiments of this disclosure, when the pH of the enteric coating solution is adjusted upward using a pH adjuster, the coating efficiency is improved, and the aforementioned problems can be minimized. Furthermore, the embodiments of this disclosure can be applied not only to hard capsules or tablets, but also to soft capsules or empty hard capsules. This will be explained in more detail in the experimental examples described later.
[0034] On the other hand, the enteric coating composition according to the embodiments of this disclosure may further include, as needed, commonly used additives in the art such as flow aids, surfactants, sweeteners, pigments (colorants), and defoamers, in the amounts used in conventional applications. These additives may be used alone or in combination of two or more.
[0035] The above-mentioned enteric coating composition can be prepared by the following method.
[0036] In one embodiment, the enteric coating composition can be prepared by dissolving a pH adjuster in purified water, adding ethanol and a plasticizer, and then dissolving the enteric compound.
[0037] More specifically, the enteric coating composition can be prepared by dissolving sodium bicarbonate (baking soda) in purified water, adding ethanol and acetylated monoglycerides as plasticizers, and then dissolving HPMCP. The amounts of each component added can be determined according to the composition of the enteric coating composition described above.
[0038] In another embodiment, the enteric coating composition can also be prepared by simultaneously dissolving the enteric compound, plasticizer, and pH adjuster in a mixed solvent consisting of purified water and an organic solvent. In this case, the amount of each component added can be determined according to the composition of the enteric coating composition described above.
[0039] On the other hand, in the above-mentioned method for preparing enteric coating compositions, the dissolution or mixing of each component can be carried out by a conventional stirring device.
[0040] enteric coating film This disclosure further provides an enteric coating film prepared from the above-described enteric coating composition. The enteric coating film can be prepared by preparing the above-described enteric coating composition into a solution (enteric coating solution), coating it onto a dosage form such as a tablet or capsule, and then drying it.
[0041] The enteric coating film according to embodiments of this disclosure may contain enteric compounds, pH adjusters, and plasticizers. Furthermore, the enteric coating film may, as needed, further contain additives commonly used in the art, such as flow aids, surfactants, sweeteners, pigments, and defoamers.
[0042] On the other hand, conventional coating methods can be used to coat enteric-coating compositions onto dosage forms such as tablets or capsules. For example, spray coating can be performed using coating apparatus such as pot coating apparatus, roller coating apparatus, fluidized bed coating apparatus, stirred fluidized bed coating apparatus, or rolling fluidized bed coating apparatus. Examples of spray coating apparatus include air spray apparatus, but are not limited to these. Furthermore, there are no particular limitations on the drying conditions after coating; for example, the drying can be maintained to the degree required for the final product.
[0043] When preparing enteric-coated films using the enteric-coating composition according to embodiments of this disclosure, compared to existing non-aqueous coating methods, the coating speed (referring to the spraying speed of the enteric-coating solution) can be increased, thereby shortening the coating time (referring to the spraying time of the enteric-coating solution) and reducing the total spray volume (referring to the total spray volume of the enteric-coating solution). Furthermore, no capsule surface turbidity or poor formulation hardening occurs after coating, thus improving coating efficiency while maintaining the coating quality of hard capsules. Moreover, when applied to soft capsules, coating can be performed even at temperatures below 20°C, particularly at 10°C, thereby maintaining coating quality and improving formulation stability. Furthermore, when applied to empty hard capsules, commercially viable coating quality can be maintained even when coating is performed in a coating machine or a fluidized bed coating machine.
[0044] Formulations containing enteric coating films This disclosure may further provide formulations comprising the aforementioned enteric coating film. Formulations according to this disclosure may be pharmaceutical formulations or food formulations. Furthermore, dosage forms according to this disclosure may include, but are not limited to, tablets, hard capsules, empty hard capsules, or soft capsules. Additionally, the size of the aforementioned tablets or capsules may be the size of commonly circulated tablets or capsules.
[0045] The contents of the formulations disclosed herein are not particularly limited. For example, the contents may include ingredients that are major components of health foods, notified ingredients that are registered in the Health Food Code, nutritional components, and ingredients that have been separately approved. Even if it is not a health food, it may contain edible oils as a general food.
[0046] Furthermore, there are no particular limitations on the form of the contents; for example, they can be liquid contents, suspension contents, or solubilized contents. More specifically, i) as liquid contents such as oils, these can be EPA and DHA-containing oils and γ-linolenic acid-containing oils in health foods, krill oil in general foods, choline alfalate in pharmaceuticals, pumpkin seed oil, etc., and there are no particular limitations on such ingredients. ii) Suspension contents in which particulate powder components are mixed in oil excipients can be milk thistle, red ginseng, hyaluronic acid, aloe vera gel, etc. in health foods, and magnesium oxide, ursodeoxycholic acid, bilberry dried extract, etc., in pharmaceuticals, and there are no particular limitations on such ingredients. In addition, iii) as contents in which powdered or viscous substances are solubilized with solvents, these can be phytosterols and phosphatidylserine in health foods, and acetaminophen, naproxen, ibuprofen, etc., in pharmaceuticals, and there are no particular limitations on such ingredients.
[0047] Furthermore, depending on the purpose of enteric coating, the contents may include substances that cause unpleasant odors or transfer odors in breath after digestion in the stomach, such as algal omega-3 oil, refined fish oil, garlic, vitamin B1, and various egg oils; or acid-sensitive intestinal bacteria such as bifidobacteria, capsaicin, and other components that irritate the stomach; iron preparations such as ferrous fumarate and dried ferrous sulfate; and antipyretics, analgesics, anti-inflammatory drugs, antitumor drugs, and antibacterial drugs, which aim to achieve a longer-lasting effect through slow release, but are not limited to these.
[0048] Test case The present disclosure will be described in more detail below through the test results of embodiments and comparative examples. However, the present disclosure is not limited to the following embodiments.
[0049] (1) Preparation and testing of hard capsules Table 1 Enteric coating solutions were prepared according to the compositions shown in Table 1 above, corresponding to Examples 1 to 3 and Comparative Examples 1 to 3. Comparative Example 1 did not contain sodium bicarbonate (pH adjuster). The plasticizer used was Almax-5000 (ILSHIN WELLS) (triacetin was used in Example 2), and HPMCP (Rakuten Precision Chemicals) was HP55. The enteric coating solution was prepared by first dissolving sodium bicarbonate (baking soda) in purified water (except for Comparative Example 1), adding ethanol and the plasticizer, and then dissolving HPMCP. The amounts added are shown in Table 1.
[0050] Next, 250 mg of excipient (lactose:microcrystalline cellulose:maltodextrin = 1:1:1) was filled into HPMC hard capsules (#2), and the enteric coating solutions of the examples and comparative examples were coated using a commercially available coating machine (SEJONG Pharmatech C30FC product; equipment conditions: 0.8Φ nozzle, Air 25 to 38 L / min). The coating conditions (spray rate, temperature, and spray time) that enabled normal coating were recorded, and the coating weight relative to the capsule weight was calculated based on these conditions.
[0051] The coated hard capsules underwent three tests: 1) appearance quality inspection, 2) filler (lactic acid bacteria) inspection, and 3) disintegration test. The results are summarized in Table 2 below. The appearance quality inspection focused on confirming whether the capsules exhibited any cloudiness, while the filler inspection focused on confirming whether the filler had hardened. The disintegration tests (first and second solutions) were conducted according to the methods specified in the Codex Alimentarius Commission for Health Foods.
[0052] Table 2 Referring to Table 2, the hard capsules coated with the enteric coating solutions corresponding to Examples 1 to 3 all passed the appearance quality inspection, filler inspection, and disintegration test. However, in Comparative Example 1 where no pH adjuster was added, or in Comparative Example 2 where the amount of pH adjuster added was less than that in the examples, the capsule surface showed turbidity, and the excipients hardened. To address this, Figure 1 Photographs of Comparative Example 1, where white turbidity occurred on the capsule surface, and Example 3, where white turbidity did not occur, are attached. Figure 1 Attached to b are photographs confirming the hardening of the excipients in Comparative Examples 1 and 2. On the other hand, in Comparative Example 3, where the amount of pH adjuster added was greater than that in the examples, although there were no abnormalities in appearance quality and filler, it disintegrated within 2 hours in the first disintegration test and was confirmed as unqualified.
[0053] In particular, a comparison of coating conditions and coating amount shows that, compared with Comparative Examples 1 to 2, the enteric coating solutions of Examples 1 to 3 can be confirmed to have increased spraying speed and can also be appropriately reduced, thus significantly shortening the spraying time, and thus confirming that the coating amount is also significantly reduced.
[0054] (2) Preparation and testing of soft capsules The enteric coating solutions for Examples 1 to 3 and Comparative Examples 1 to 3 as described in Table 1 above were prepared, and Omega-3 soft capsules (Oblong 15, 750 mg) were coated using a commercially available coating machine (SEJONG Pharmatech C30FC product). The coating temperature at which coating could be carried out normally was recorded. The coated soft capsules were subjected to appearance quality inspection and disintegration test, and the results are summarized in Table 3 below.
[0055] Table 3 Referring to Table 3, the enteric coating solutions corresponding to Examples 1 to 3, when used for soft capsule coating, all showed satisfactory results in appearance quality inspection and disintegration test. However, if no pH adjuster was added to the enteric coating solution of Comparative Example 1, or if the amount of pH adjuster added to Comparative Example 2 was less than that of the examples, the problem of turbidity appearing on the capsule surface also occurred. Figure 2 Photographs are attached to Comparative Example 1, showing turbidity on the surface (junction) of Omega-3 soft capsules, and Example 3, showing no turbidity. On the other hand, although the appearance quality was normal in Comparative Example 3, where the amount of pH adjuster added was greater than that in the examples, it failed the first disintegration test.
[0056] In particular, when the soft capsules were coated using the enteric coating solutions corresponding to Examples 1 to 3, it was confirmed that coating could be performed even at low temperatures of 10 to 15°C. Therefore, the embodiments of this disclosure can both prevent possible turbidity of the coating film in the soft capsules and enable coating at low temperatures below 20°C, thereby improving the stability of the liquid formulation.
[0057] Table 4 To confirm whether differences in coating quality occur depending on the type of commercially available coating machine, enteric coating solutions corresponding to Examples 4, 5, and Comparative Example 4 were prepared. Almax-5000 (ILSHIN WELLS) was used as the plasticizer, and HP50 was used by HPMCP (Rakuten Fine Chemicals).
[0058] Next, empty hard capsules (HPMC white capsules #0) were prepared, and 30,000 capsules were coated using both a commercially available fully perforated coating machine (SEJONG Pharmatech C30FC product; equipment conditions: 0.8Φ nozzle, air 25 to 38 L / min) and a fluidized bed coating machine (Chinese manufacturer DPL-1 product; equipment conditions: 2.0Φ nozzle). The coating conditions (spray speed, temperature, and spray time) that allowed for successful coating were recorded, and the coating weight relative to the capsule weight was calculated based on these conditions.
[0059] The coated hollow hard capsules underwent appearance quality inspection and disintegration test, and the results are summarized in Table 5 below. The appearance quality inspection focused on confirming whether the capsules exhibited any cloudiness. The disintegration test (first and second solutions) was conducted according to the methods specified in the Codex Alimentarius for Health Foods. During the disintegration test, 500 mg of excipient (lactose:microcrystalline cellulose:maltodextrin = 1:1:1) was used as the filling material.
[0060] Table 5 Referring to Table 5, the hollow hard capsules coated with the enteric coating solutions of Comparative Example 4, Example 4, and Example 5 were all well coated. However, in Comparative Example 4, the enteric substance failed to adhere well to the surface of the hollow hard capsules, resulting in substandard appearance quality and failure in the first disintegration test. Conversely, in Example 4 or Example 5, the enteric substance adhered well to the surface of the hollow hard capsules, achieving satisfactory appearance quality and passing the disintegration test. Figure 3 The photograph shows the separated state of the coated hollow hard capsules in Example 5 after coating. That is, it can be confirmed that the enteric coating solution according to the embodiments of this disclosure has good coating quality even when applied to hollow hard capsules in commonly used commercial coating machines (commercially available fully perforated coating machines, fluidized bed coating machines), thus confirming its commercial applicability.
[0061] The embodiments of this disclosure have been described above. However, those skilled in the art to which this disclosure pertains can make various modifications to this disclosure by simple design changes, omission of some constituent elements, or changes in simple uses, depending on the specific application of the technology, within the scope of the technical concept described in the claims. Such modifications are obviously also included within the scope of the claims of this disclosure.
Claims
1. An enteric coating composition, wherein, Include: Hydroxypropyl methylcellulose phthalate (HPMCP); Plasticizers selected from triacetin or acetylated monoglycerides; A mixed solvent containing purified water and ethanol; and A pH adjuster to adjust the pH to the range of 2.5 to 7.
0. The pH adjuster is sodium bicarbonate (baking soda, NaHCO3).
2. The enteric coating composition according to claim 1, wherein, Hydroxypropyl methylcellulose phthalate (HPMCP) 50 to 150 parts by weight, purified water 125 to 210 parts by weight, ethanol 725 to 980 parts by weight, plasticizer 10 to 65 parts by weight, pH adjuster 1 to 6 parts by weight.
3. The enteric coating composition according to claim 1, wherein, The hydroxypropyl methylcellulose phthalate (HPMCP) is selected from HPMCP-HP 50, HPMCP-HP 55 or HPMCP-HP 55S.
4. An enteric coating film formed from the enteric coating composition according to any one of claims 1 to 3.
5. A formulation comprising the enteric coating film according to claim 4.
6. The formulation according to claim 5, wherein, The dosage form of the preparation is selected from tablets, hard capsules, empty hard capsules and soft capsules.
Citation Information
Patent Citations
Enteric coated soft capsule composition containing purified fish oil and its preparation method
KR101380652B1
Enteric coating composition, enteric coating layer, and food formulation
KR1020150079282A
Enteric coating composition, solid preparation and method for producing solid preparation
KR1020200117883A
